An exploratory analysis of the cost‐effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model
Article in Diabetic Medicine (March 2024)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
Article in Diabetic Medicine (March 2024)
Preprint in arXiv (February 2024)
Article in Diabetes Technology & Therapeutics (February 2024)